Pricing Log in Create free account

BioMarin Pharmaceutical Inc. (BMRN) vs Corcept Therapeutics Incorporated (CORT)

BioMarin Pharmaceutical Inc. and Corcept Therapeutics Incorporated are both Biotechnology companies. Corcept Therapeutics Incorporated is the larger, with a market value of $12.3B against $10.9B — 1.1× the size. BioMarin Pharmaceutical Inc. trades at the lower P/E: 144× against 212×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 16.0% against 11.2%. Corcept Therapeutics Incorporated has the higher net margin (6.53% vs 2.14%) and the higher return on invested capital (1.01% vs 0.97%). Across the 22 metrics below, BioMarin Pharmaceutical Inc. leads on 11 and Corcept Therapeutics Incorporated on 11.

Valuation

Metric BMRN CORT Biotechnology median
P/E 143.89 211.85 8.50
P/S 3.10 13.97 9.71
P/B 1.67 16.45 2.13
Price to free cash flow 14.59 108.57 20.82
EV/EBITDA 46.69 3,040.10 0.64
EV/Sales 4.08 13.62 9.21
Earnings yield 0.69% 0.47% (33.15%)
Free cash flow yield 6.85% 0.92% (25.50%)

Profitability

Metric BMRN CORT Biotechnology median
Gross margin 76.12% 98.30% 65.16%
Operating margin 4.38% 0.77% 0.00%
Net margin 2.14% 6.53% 0.00%
Free cash flow margin 21.28% 12.87% 0.00%
Return on equity 1.18% 8.08% (56.36%)
Return on assets 0.76% 6.41% (48.04%)
Return on invested capital 0.97% 1.01% 0.00%

Growth

Metric BMRN CORT Biotechnology median
Revenue growth (TTM) 11.20% 16.02% 6.02%
EPS growth (last fiscal year) (18.55%) (33.33%) 30.26%
Revenue growth, 5-year CAGR 11.60% 16.56% 9.41%
Net income growth, 5-year CAGR (16.39%) (1.52%) 0.00%

Health

Metric BMRN CORT Biotechnology median
Debt to equity 0.66 0.00 0.00
Current ratio 2.39 2.86 4.72
Net debt to EBITDA (1.99) (8.83) 0.96

Dividend

Metric BMRN CORT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BMRN CORT Biotechnology median
Market cap 10.85b 12.26b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack